Impact of the Opioid Epidemic on Drug Testing
- PMID: 33230043
- DOI: 10.1097/FTD.0000000000000841
Impact of the Opioid Epidemic on Drug Testing
Abstract
Background: This review provides a description of how the opioid epidemic has impacted drug testing.
Methods: Four major service areas of drug testing were considered, including emergency response, routine clinical care, routine forensics, and death investigations.
Results: Several factors that the opioid epidemic has impacted in drug testing are discussed, including specimens, breadth of compounds recommended for testing, time to result required for specific applications, analytical approaches, interpretive support requirements, and examples of published practice guidelines.
Conclusions: Both clinical and forensic laboratories have adapted practices and developed new testing approaches to respond to the opioid epidemic. Such changes are likely to continue evolving in parallel with changes in both prescription and nonprescription opioid availability and use patterns, as well as emerging populations that are affected by the "waves" of the opioid epidemic.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Ugalmugle S, Swain R. Drug of Abuse Testing Market Size by Product (Analyzers {Breath Analyzers Immunoassay Analyzers, Chromatographic Analyzers}), Rapid Testing Devices, Consumables), by Sample (Urine, Saliva, Hair), by End-Use (Hospitals, Forensic Laboratories, Diagnostic Laboratories, Law Enforcement Agencies), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019–2025 Selbyville, DE: Global Market Insights, Inc.: 2019.
-
- Military Drug Program Historical Timeline. Available at: https://prhome.defense.gov/ForceResiliency/DDRP/Timeline/ . Accessed October 20, 2020.
-
- Robins LN. The Vietnam Drug User Returns: Final Report. Special Action Office Monograph, Series A, Number 2. Washington, DC: US Government Printing Office, 1974.
-
- Reagan R. Executive Order 12564 Drug-free Federal workplace, 51 Federal Register 32889. 17; 1986 (September 17, 1986).
-
- O'Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region—United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66:897–903.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical